
Quotient Limited QTNT
Quarterly report 2022-Q4
added 02-09-2023
Quotient Limited Current Ratio 2011-2026 | QTNT
Annual Current Ratio Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.861 | 4.83 | 4.59 | 1.92 | 1.37 | 2.89 | 0.914 | 1.5 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.83 | 0.861 | 2.36 |
Quarterly Current Ratio Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.36 | 0.41 | 0.54 | 0.57 | 0.62 | 0.75 | 0.82 | 0.84 | 1.01 | 1.03 | 1.14 | 0.87 | 1.08 | 0.79 | 0.9 | 1.01 | 1.15 | 0.91 | 0.78 | 0.89 | 1.03 | 0.88 | 1.03 | 0.82 | 0.96 | 1.37 | 1.38 | 1.64 | 1.41 | 1.13 | 0.9 | 0.98 | 0.89 | 1.26 | 1.67 | 0.97 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.67 | 0.36 | 0.966 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Bioventus
BVS
|
1.5 | $ 9.26 | 1.09 % | $ 617 M | ||
|
Biodesix
BDSX
|
1.27 | $ 14.6 | -3.63 % | $ 1.89 B | ||
|
DarioHealth Corp.
DRIO
|
4.85 | $ 8.45 | 9.74 % | $ 33.7 M | ||
|
DexCom
DXCM
|
1.76 | $ 66.09 | -1.12 % | $ 25.8 B | ||
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
ICON Public Limited Company
ICLR
|
2.29 | $ 103.08 | 3.09 % | $ 8.5 B | ||
|
IDEXX Laboratories
IDXX
|
1.92 | $ 573.29 | -0.42 % | $ 46.1 B | ||
|
Illumina
ILMN
|
6.69 | $ 124.4 | -1.43 % | $ 19.8 B | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
10.2 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | ||
|
Medpace Holdings
MEDP
|
1.3 | $ 466.6 | -0.04 % | $ 13.5 B | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 4.62 | -1.28 % | $ 428 M | ||
|
National Research Corporation
NRC
|
1.12 | $ 17.52 | 1.98 % | $ 392 M | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
Natera
NTRA
|
2.02 | $ 196.15 | -0.62 % | $ 19.3 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 165.13 | -0.46 % | $ 8.18 B | ||
|
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | ||
|
OPKO Health
OPK
|
2.64 | $ 1.17 | -1.68 % | $ 812 M | ||
|
Pacific Biosciences of California
PACB
|
1.01 | $ 1.35 | -2.88 % | $ 405 M | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
ENDRA Life Sciences
NDRA
|
2.35 | $ 4.59 | 22.4 % | $ 2.46 M | ||
|
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | ||
|
Personalis
PSNL
|
4.02 | $ 7.32 | -4.94 % | $ 434 M | ||
|
Interpace Biosciences
IDXG
|
0.87 | $ 1.73 | 2.37 % | $ 7.59 M | ||
|
RadNet
RDNT
|
1.56 | $ 59.41 | -2.06 % | $ 4.47 B | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | ||
|
Celcuity
CELC
|
1.27 | $ 114.81 | 4.16 % | $ 4.53 B | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
Senseonics Holdings
SENS
|
1.94 | $ 6.56 | -2.96 % | $ 274 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 268.38 | 0.89 % | $ 22.3 B | ||
|
NeoGenomics
NEO
|
2.6 | $ 7.76 | -0.13 % | $ 994 M | ||
|
Soleno Therapeutics
SLNO
|
4.96 | $ 31.83 | -0.03 % | $ 1.62 B | ||
|
Psychemedics Corporation
PMD
|
2.18 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
4.93 | $ 27.2 | -0.15 % | $ 35.3 M |